✦ LIBER ✦

PCN17 THE COST-EFFECTIVENESS OF CETUXIMAB IN COMBINATION WITH IRINOTECAN FORTHE TREATMENT OF PATIENTS WITH EGFR-EXPRESSING METASTATIC COLORECTAL CANCER AFTER FAILURE OF IRINOTECAN-INCLUDING CYTOTOXIC THERAPY IN SCOTLAND

✍ Scribed by D Tilden; D Thurley; J White; M Aristides

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN70 MODELLING THE COST EFFECTIVENESS O

✍ C Holmberg; R Aultman; U Siebert; E Sabate; M Gyldmark 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

3055 POSTER Cetuximab plus irinotecan in

✍ C. de Cerqueira Mathias; F. Perazzo; S. Simon; L. Fein; J. Hidalgo; A.M. Murad; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Optimisation of irinotecan dose in the t

✍ Van Cutsem, E; Dirix, L; Van Laethem, J-L; Van Belle, S; Borner, M; Gonzalez Bar 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 108 KB

Cetuximab (C225, Erbitux) in combination

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 306 KB

OP4. Cost-effectiveness of Irinotecan (C

✍ G Blijham; C Schmitt; P Aussage; B Henry-Launois; B Jolain; P Hérait 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 164 KB